Methods and Issues to Consider for Detection of Safety Signals From Spontaneous Reporting Databases: A Report of the DIA Bayesian Safety Signal Detection Working Group-Reference-Cited by-同舟云学术

Methods and Issues to Consider for Detection of Safety Signals From Spontaneous Reporting Databases: A Report of the DIA Bayesian Safety Signal Detection Working Group

Published:2015-01 Issue:1 Volume:49 Page:65-75
ISSN:2168-4790
Container-title:Therapeutic Innovation & Regulatory Science
language:en
Short-container-title:Ther Innov Regul Sci

Author:

Gould A. Lawrence,Lystig Theodore C.,Lu Yun,Fu Haoda,Ma Haijun

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1177/2168479014533114.pdf

Reference60 articles.

1. Rothwell PM. External validity of randomised clinical trials: “To whom do the results of this trial apply”? Lancet. 2005;365:82–93.

2. Hammad TA, Neyarapally GA, Iyasu S, Staffa JA, Dal Pan G. The future of population-based postmarket drug risk assessment: a regulator’s perspective. Clin Pharmacol Ther. 2013;94:349–358.

3. Ahmed I, Thiessard F, Miremont-Salame G, Begaud B, Tubert-Bitter P. Pharmacovigilance data mining with methods based on false discovery rates: a comparative simulation study. Clin Pharmacol Ther. 2010;88:492–498.

4. Ahmed I, Dalmasso C, Haramburu F, Thiessard F, Broet P, Tubert-Bitter P. False discovery rate estimation for frequentist pharmacovigilance signal detection methods. Biometrics. 2010;66:301–309.

5. Almenoff J, Tonning JM, Gould AL, et al. Perspectives on the use of data mining in pharmacovigilance. Drug Saf. 2005;28:981–1007.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacovigilance and Adverse Drug Reaction Reporting among the General Public in Lithuania: A Cross-Sectional Study;Healthcare;2023-04-14

2. Assessment of pancreatitis associated with tocilizumab use using the United States Food and Drug Administration Adverse Event Reporting System database;Scientific Reports;2021-09-22

3. Challenges Associated with the Safety Signal Detection Process for Medical Devices;Medical Devices: Evidence and Research;2021-02

4. Assessment of the cardiovascular adverse effects of drug-drug interactions through a combined analysis of spontaneous reports and predicted drug-target interactions;PLOS Computational Biology;2019-07-19

5. Statistical Practices of Safety Monitoring: An Industry Survey;Therapeutic Innovation & Regulatory Science;2019-05